Psychotropic Drugs Contraindicated in Glaucoma Patients
Tricyclic antidepressants, benzodiazepines, topiramate, and phentermine are contraindicated in patients with glaucoma due to their potential to precipitate acute angle-closure glaucoma or worsen intraocular pressure. 1, 2
Mechanism of Risk
The risk of psychotropic medications in glaucoma patients primarily relates to their potential to:
- Induce angle-closure glaucoma - Particularly in anatomically predisposed patients with narrow angles
- Elevate intraocular pressure (IOP) - Worsening existing glaucoma
- Cause other ocular adverse effects - Including mydriasis, accommodation problems, and retinopathy
Specific Contraindicated Medications
1. Tricyclic Antidepressants (TCAs)
- Mechanism: Anticholinergic effects cause mydriasis (pupil dilation) that can precipitate angle closure 1
- Risk level: High - when patients with narrow angles are given TCAs, they appear to experience induction of glaucomatous attacks 1
- Examples: Amitriptyline, imipramine, nortriptyline
2. Topiramate
- Mechanism: Can cause an allergic-type reaction displacing structures of the lens and ciliary body 1
- Risk level: High - frequently associated with significant ocular symptoms including acquired myopia and angle-closure glaucoma 1
3. Benzodiazepines
- Mechanism: May affect eye movements and potentially worsen glaucoma 3, 1
- Risk level: Moderate to high - should be avoided in patients diagnosed with glaucoma 3
- Examples: Diazepam, lorazepam, clonazepam
4. Phentermine
- Mechanism: Sympathomimetic effects can increase IOP
- Risk level: High - explicitly contraindicated in glaucoma according to FDA labeling 2
5. First-Generation Antipsychotics (at high doses)
- Mechanism: Can cause mydriasis and anticholinergic effects
- Risk level: Moderate - especially chlorpromazine and thioridazine at high doses over prolonged periods 1
- Concern: Can cause lenticular opacifications and retinopathy with long-term use
Medications Requiring Caution
1. Selective Serotonin Reuptake Inhibitors (SSRIs)
- Risk level: Low to moderate - may lead to an added risk of developing angle-closure glaucoma, but only in predisposed eyes 1
- Current evidence: Best evidenced as having no association with glaucoma among psychotropics 3
2. Second-Generation Antipsychotics
- Risk level: Variable - ziprasidone requires special attention 3
- Monitoring: Close ophthalmological follow-up recommended
3. Carbamazepine
- Risk level: Variable - case reports of IOP elevation 4
- Monitoring: May require IOP monitoring, especially in pseudoexfoliative glaucoma patients
Clinical Approach to Psychotropic Medication in Glaucoma Patients
Determine glaucoma type:
- Open-angle glaucoma - fewer medication restrictions
- Angle-closure glaucoma or narrow angles - higher risk with anticholinergic medications
Assess anatomical risk factors:
- Shallow anterior chamber
- Narrow angles
- Pseudoexfoliation
Medication selection algorithm:
- First-line options: SSRIs and SNRIs (lowest risk)
- Second-line options: Second-generation antipsychotics (except ziprasidone)
- Avoid if possible: TCAs, benzodiazepines, topiramate, phentermine
Monitoring recommendations:
- Baseline ophthalmological examination before starting high-risk medications
- Regular IOP monitoring for patients on moderate-risk medications
- Immediate ophthalmological evaluation for any visual symptoms
Important Caveats
- Patients with open-angle glaucoma generally have fewer medication restrictions than those with angle-closure glaucoma
- Individual susceptibility varies significantly - some patients may tolerate medications that are theoretically contraindicated
- The risk of untreated psychiatric illness must be weighed against potential ocular risks
- All glaucoma patients on psychotropic medications should be under strict ophthalmological supervision 3
Warning Signs Requiring Immediate Attention
- Sudden vision changes
- Eye pain or headache
- Halos around lights
- Nausea and vomiting with eye pain
- Redness of the eye
These symptoms may indicate acute angle-closure glaucoma, which is a medical emergency requiring immediate ophthalmological intervention.